Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa : a retrospective cohort analysis
dc.contributor.author | Bouton, Tara C. | en_ZA |
dc.contributor.author | De Vos, Margaretha | en_ZA |
dc.contributor.author | Ragan, Elizabeth J. | en_ZA |
dc.contributor.author | White, Laura F. | en_ZA |
dc.contributor.author | Van Zyl, Leonie | en_ZA |
dc.contributor.author | Theron, Danie | en_ZA |
dc.contributor.author | Horsburgh, C. Robert | en_ZA |
dc.contributor.author | Warren, Robin M. | en_ZA |
dc.contributor.author | Jacobson, Karen R. | en_ZA |
dc.date.accessioned | 2021-10-25T06:31:03Z | |
dc.date.available | 2021-10-25T06:31:03Z | |
dc.date.issued | 2019-10-17 | |
dc.description | CITATION: Bouton, T. C., et al. 2019. Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa : a retrospective cohort analysis. PLoS ONE, 14(10). doi:10.1371/journal.pone.0223308 | |
dc.description | The original publication is available at https://journals.plos.org/plosone/ | |
dc.description.abstract | ENGLISH ABSTRACT: South Africa led the world with guidelines on bedaquiline (BDQ) use as a single drug substitution to manage rifampin resistant tuberculosis regimen toxicity. We examined reasons for giving BDQ in a retrospective cohort: >75% of patients were switched to BDQ for toxicity (ototoxicity or renal dysfunction) rather than drug resistance. | en_ZA |
dc.description.uri | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0223308 | |
dc.description.version | Publisher's version | |
dc.format.extent | 6 pages | en_ZA |
dc.identifier.citation | Bouton, T. C., et al. 2019. Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa : a retrospective cohort analysis. PLoS ONE, 14(10). doi:10.1371/journal.pone.0223308 | |
dc.identifier.issn | 1932-6203 (online) | |
dc.identifier.other | doi:10.1371/journal.pone.0223308 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/123284 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Public Library of Science | en_ZA |
dc.rights.holder | Authors retain rights | en_ZA |
dc.subject | Tuberculosis -- Treatment | en_ZA |
dc.subject | Bedaquiline (BDQ) | en_ZA |
dc.subject | Antibiotics | en_ZA |
dc.subject | Rifampicin | en_ZA |
dc.subject | Multidrug-resistant tuberculosis | en_ZA |
dc.title | Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa : a retrospective cohort analysis | en_ZA |
dc.type | Article | en_ZA |